As leukemia options grow, drugs jockey to be first-line therapies

被引：1
|
作者：
Dolgin, Elie
机构：
来源：
NATURE MEDICINE | 2013年 / 19卷 / 01期
关键词：
CHRONIC MYELOID-LEUKEMIA; IMATINIB;
D O I：
10.1038/nm0113-7
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] Evaluation of efficacy and tolerability of first-line therapies in NMOSD
    Poupart, Julien
    Giovannelli, Jonathan
    Deschamps, Romain
    Audoin, Bertrand
    Ciron, Jonathan
    Maillart, Elisabeth
    Papeix, Caroline
    Collongues, Nicolas
    Bourre, Bertrand
    Cohen, Mickael
    Wiertlewski, Sandrine
    Outteryck, Olivier
    Laplaud, David
    Vukusic, Sandra
    Marignier, Romain
    Zephir, Helene
    NEUROLOGY, 2020, 94 (15) : E1645 - E1656
  • [22] How do multiple sclerosis patients in the NARCOMS registry navigate their treatment options beyond first-line therapies?
    Salter, A.
    Tyry, T.
    Cofield, S.
    Agashivala, N.
    Ryu, S.
    Marrie, R. A.
    Fox, R.
    Cutter, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 224 - 225
  • [23] Future options for first-line therapy of advanced ovarian cancer
    Du Bois, A
    Pfisterer, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 : 42 - 50
  • [24] First-line treatment options for patients with metastatic colorectal cancer
    Richard L Schilsky
    Nature Clinical Practice Oncology, 2004, 1 : 70 - 71
  • [25] Treatment options for glioblastoma failing standard first-line treatment
    Wick, W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 33 - 33
  • [26] Options in metastatic urothelial cancer after first-line therapy
    Alimohamed, Nimira S.
    Sridhar, Srikala S.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2015, 9 (03) : 255 - 260
  • [27] Optimizing first-line treatment options for patients with advanced NSCLC
    Wakelee, H
    Belani, CP
    ONCOLOGIST, 2005, 10 : 1 - 10
  • [28] First-line treatment options for patients with metastatic colorectal cancer
    Schilsky, Richard L.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 70 - 71
  • [29] Treatment options after first-line immunotherapy in metastatic NSCLC
    Santos, Edgardo S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 221 - 228
  • [30] First-line treatment options in metastatic renal cell cancer
    Kapoor, Anil
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (11-12): : S236 - S238
12345